Results: 1-25 | 26-50 | 51-68
Results: 1-25/68

Authors: Lincoff, AM
Citation: Am. Lincoff, Anticoagulant and antiplatelet drugs, CATHET C IN, 54(4), 2001, pp. 514-520

Authors: L'Allier, PL Lincoff, AM
Citation: Pl. L'Allier et Am. Lincoff, Platelet glycoprotein IIb/IIIa inhibitors combined with fibrinolytic agents to treat acute myocardial infarction, J THROMB TH, 11(1), 2001, pp. 83-91

Authors: Wang, K Zhou, ZM Zhou, XR Tarakji, K Topol, EJ Lincoff, AM
Citation: K. Wang et al., Prevention of intimal hyperplasia with recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in the porcine coronary artery balloon injury model, J AM COL C, 38(2), 2001, pp. 577-582

Authors: Greenbaum, AB Harrington, RA Hudson, MP MacAulay, CM Wilcox, RG Simoons, ML Berdan, LG Guerci, A Cokkinos, DV Kitt, MM Lincoff, AM Topol, EJ Califf, RM Ohman, EM
Citation: Ab. Greenbaum et al., Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes, J AM COL C, 37(2), 2001, pp. 492-498

Authors: Topol, EJ Califf, RM Van de Werf, F Willerson, JT Booth, J White, H Clayman, M Deckelbaum, L Lincoff, AM Ohman, EM Bates, E Gibler, WB Hochman, J Kleiman, N Grinfeld, L Aylward, P Armstrong, PW Heikkila, J Vahanian, A Steg, G Bode, C Adgy, AAJ Guetta, V Ardissino, D Savonitto, S Bar, F Simoons, M Kontny, F White, H Sadowski, Z Seabra-Gomes, R Dalby, A Betriu, A Swahn, E Wilcox, R Frye, RL Bertrand, ME DeMets, D Fox, KKA Fuster, V Lee, KL McCarthy, C Waller, M Scherer, J van de Kerkhove, A Kukulewicz, L Booth, JE Del Valle, M Hibert, D Brannon, D
Citation: Ej. Topol et al., Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO randomised trial, LANCET, 357(9272), 2001, pp. 1905-1914

Authors: Aronow, HD Topol, EJ Roe, MT Houghtaling, PL Wolski, KE Lincoff, AM Harrington, RA Califf, RM Ohman, EM Kleiman, NS Keltai, M Wilcox, RG Vahanian, A Armstrong, PW Lauer, MS
Citation: Hd. Aronow et al., Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study, LANCET, 357(9262), 2001, pp. 1063-1068

Authors: Akkerhuis, KM Deckers, JW Lincoff, AM Tcheng, JE Boersma, E Anderson, K Balog, C Califf, RM Topol, EJ Simoons, ML
Citation: Km. Akkerhuis et al., Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention, J AM MED A, 286(1), 2001, pp. 78-82

Authors: Tcheng, JE Kereiakes, DJ Lincoff, AM George, BS Kleiman, NS Sane, DC Cines, DB Jordan, RE Mascelli, MA Langrall, MA Damaraju, L Schantz, A Effron, MB Braden, GA
Citation: Je. Tcheng et al., Abciximab readministration - Results of the ReoPro readministration registry, CIRCULATION, 104(8), 2001, pp. 870-875

Authors: Park, SH Marso, SP Zhou, ZM Foroudi, F Topol, EJ Lincoff, AM
Citation: Sh. Park et al., Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus, CIRCULATION, 104(7), 2001, pp. 815-819

Authors: Tardiff, BE Jennings, LK Harrington, RA Gretler, D Potthoff, RF Vorchheimer, DA Eisenberg, PR Lincoff, AM Labinaz, M Joseph, DM McDougal, MF Kleiman, NS
Citation: Be. Tardiff et al., Pharmacodynamics and pharmacokinetics of eptifibatide in patients with acute coronary syndromes - Prospective analysis from PURSUIT, CIRCULATION, 104(4), 2001, pp. 399-405

Authors: Lauer, MA Houghtaling, PL Peterson, JG Granger, CB Bhatt, DL Sapp, SK Simoons, ML Harrington, RA Topol, EJ Lincoff, AM
Citation: Ma. Lauer et al., Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acutecoronary syndromes - Observations from the platelet IIb/IIIa in unstable angina: Receptor suppression using integrilin therapy (PURSUIT) trial, CIRCULATION, 104(23), 2001, pp. 2772-2777

Authors: Chew, DP Bhatt, DL Lincoff, AM Moliterno, DJ Brener, SJ Wolski, KE Topol, EJ
Citation: Dp. Chew et al., Defining the optimal activated clotting times during percutaneous coronaryintervention: Aggregate results from 6 randomized, controlled trials - Response, CIRCULATION, 104(22), 2001, pp. E124-E124

Authors: Ellis, SG Brener, SJ Lincoff, AM Moliterno, DJ Whitloe, PL Schneider, JP
Citation: Sg. Ellis et al., beta-blockers before percutaneous coronary intervention do not attenuate postprocedural creatine kinase isoenzyme rise, CIRCULATION, 104(22), 2001, pp. 2685-2688

Authors: Lincoff, AM Kereiakes, DJ Mascelli, MA Deckelbaum, LI Barnathan, ES Patel, KK Frederick, B Nakada, MT Topol, EJ
Citation: Am. Lincoff et al., Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization, CIRCULATION, 104(2), 2001, pp. 163-167

Authors: Chew, DP Bhatt, DL Lincoff, AM Moliterno, DJ Brener, SJ Wolski, KE Topol, EJ
Citation: Dp. Chew et al., Optimal activated clotting time during percutaneous coronary intervention - Response, CIRCULATION, 104(15), 2001, pp. E83-E84

Authors: Chew, DP Bhatt, DL Lincoff, AM Moliterno, DJ Brener, SJ Wolski, KE Topol, EJ
Citation: Dp. Chew et al., Defining the optimal activated clotting time during percutaneous coronary intervention - Aggregate results from 6 randomized, controlled trials, CIRCULATION, 103(7), 2001, pp. 961-966

Authors: Steinhubl, SR Talley, JD Braden, GA Tcheng, JE Casterella, PJ Moliterno, DJ Navetta, FI Berger, PB Popma, JJ Dangas, G Gallo, R Sane, DC Saucedo, JF Jia, G Lincoff, AM Theroux, P Holmes, DR Teirstein, PS Kereiakes, DJ
Citation: Sr. Steinhubl et al., Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention - Results of the GOLD (AU-Assessing Ultegra) multicenter study, CIRCULATION, 103(21), 2001, pp. 2572-2578

Authors: Steinhubl, SR Ellis, SG Wolski, K Lincoff, AM Topol, EJ
Citation: Sr. Steinhubl et al., Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events - Data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) trial, CIRCULATION, 103(10), 2001, pp. 1403-1409

Authors: Tcheng, JE Talley, JD O'Shea, JC Gilchrist, IC Kleiman, NS Grines, CL Davidson, CJ Lincoff, AM Califf, RM Jennings, LK Kitt, MM Lorenz, TJ
Citation: Je. Tcheng et al., Clinical pharmacology of higher dose eptifibatide in percutaneous coronaryintervention (the PRIDE study), AM J CARD, 88(10), 2001, pp. 1097-1102

Authors: Peterson, JG Topol, EJ Roe, MT Sapp, SK Lincoff, AM Deckers, JW Blackstone, EH Harrington, RA Califf, RM Lauer, MS
Citation: Jg. Peterson et al., Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes, AM J CARD, 87(5), 2001, pp. 532-536

Authors: L'Allier, PL Lincoff, AM
Citation: Pl. L'Allier et Am. Lincoff, Early invasive versus early conservative strategies for acute coronary syndromes, ACUTE CORONARY SYNDROMES, SECOND EDITION, 2001, pp. 391-417

Authors: Roe, MT Sapp, SK Lincoff, AM
Citation: Mt. Roe et al., Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes, CLEV CLIN J, 67(2), 2000, pp. 131-140

Authors: Herrmann, HC Moliterno, DJ Ohman, EM Stebbins, AL Bode, C Betriu, A Forycki, F Miklin, JS Bachinsky, WB Lincoff, AM Califf, RM Topol, EJ
Citation: Hc. Herrmann et al., Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction - Results from the SPEED (GUSTO-4 pilot) trial, J AM COL C, 36(5), 2000, pp. 1489-1496

Authors: Lincoff, AM
Citation: Am. Lincoff, First clinical investigation of a tissue-factor inhibitor administered during percutaneous coronary revascularization: A randomized, double-blinded, dose-escalation trial - Assessing safety and efficacy of FFR-FVIIa in percutaneous transluminal coronary angioplasty (ASIS) trial, J AM COL C, 36(1), 2000, pp. 312-313

Authors: Lincoff, AM Califf, RM Topol, EJ
Citation: Am. Lincoff et al., Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease, J AM COL C, 35(5), 2000, pp. 1103-1115
Risultati: 1-25 | 26-50 | 51-68